What Sildenafil Genfar Treats: Main Uses and Benefits

Sildenafil Genfar is commonly used across domains where short-term symptom management is appropriate.

This medication is commonly applied in the domain of male sexual health to address erectile dysfunction (ED) and also plays a role in the long-term management of Pulmonary Arterial Hypertension (PAH). For men, it is considered relevant for those experiencing the inability to achieve or maintain a penile erection. For PAH patients, it helps address symptom clusters like shortness of breath and exertional fatigue, offering supportive relief that eases the overall symptomatic burden of this serious condition.

In both contexts, Sildenafil Genfar may assist with maintaining functional stability and supports general well-being during symptomatic phases. It is also applied when erectile difficulties are associated with established systemic conditions, such as diabetes mellitus, or follow specific surgical interventions.

Quick Fact: Support for Key Symptom Domains
Helps address symptoms that create noticeable physiological strain, such as the inability to maintain an erection or exertional limitations due to pulmonary hypertension.

Regulatory References

1. NIH MedlinePlus overview

Sildenafil Genfar is primarily indicated for use in adult men (aged 18 years and over) for Erectile Dysfunction. It is contraindicated for several specific populations, as explicitly documented in regulatory labels.

Contraindicated Populations

Category	Prohibited Use Status
Nitrate Users	Concomitant use with nitrates or nitric oxide donors in any form is an absolute contraindication, due to risk of severe hypotension.
Cardiovascular Risk	Contraindicated in patients with recent stroke or myocardial infarction (heart attack), severe hypotension (<90/50 mmHg), or severe cardiac failure.
Ocular History	Prohibited for patients with a history of Non-arteritic anterior ischemic optic neuropathy (NAION) or known hereditary degenerative retinal disorders.
Organ Function	Severe hepatic impairment is an absolute contraindication, as safety has not been established in this subgroup.

Eligibility-Related Restrictions

Use is not indicated for individuals under 18 years of age for Erectile Dysfunction. Use in pregnant or breastfeeding women is not indicated for ED, and data are limited for other uses. For older adults (ge 65 years) and patients with severe renal impairment, initial use requires a lower starting dose due to reduced drug clearance.

Interactions with other medicines and products

Sildenafil can interact with other medicines, which may increase the risk of side effects or affect the medicine’s concentration in the body. Consult a healthcare provider regarding all concurrent medications and supplements before starting treatment.

Contraindicated Combinations

Sildenafil is contraindicated (must not be used) with:

• Nitrates and Nitric Oxide Donors: Medicines containing organic nitrates, such as nitroglycerin, isosorbide dinitrate, or isosorbide mononitrate, in any form. This combination can cause a severe and life-threatening drop in blood pressure.
• Guanylate Cyclase (sGC) Stimulators: Medicines like Riociguat, as combining them with sildenafil can lead to dangerous levels of hypotension.

Interactions Requiring Dose Adjustments

Sildenafil is mainly broken down by the liver enzyme CYP3A4. Medicines that strongly inhibit this enzyme increase the level of sildenafil in the blood, raising the risk of side effects.

• Potent CYP3A4 Inhibitors (e.g., Ritonavir, Ketoconazole, Itraconazole, Erythromycin): If you are taking a potent CYP3A4 inhibitor, the starting dose of sildenafil is often reduced, typically to 25 mg. With Ritonavir, a dose higher than 25 mg within a 48-hour period is usually not permitted.

Other Important Interactions

• Alpha-Blockers: Concomitant use with alpha-blockers (e.g., Tamsulosin) may cause symptomatic hypotension (low blood pressure with symptoms). Sildenafil should be initiated at a 25 mg dose, and the patient should be stable on the alpha-blocker therapy before starting sildenafil.

Sildenafil Genfar acts as a highly selective competitive inhibitor of the enzyme Phosphodiesterase type 5 ( PDE5), which regulates vascular smooth muscle tone. By binding to the enzyme's active site, the drug prevents the breakdown of the signaling molecule cyclic Guanosine Monophosphate ( cGMP), which is central to relaxation pathways.

The drug works by amplifying the natural NO-cGMP signaling cascade, acting downstream of the initial Nitric Oxide ( NO) release. This leads to sustained, high concentrations of cGMP within smooth muscle cells, promoting sustained relaxation (vasodilation) and a resulting increase in local regional blood flow.

The mechanism is contingent upon the presence of an initial physiological signal and is inactive without the release of NO. A functional constraint involves limited cross-inhibition of the retinal enzyme PDE6, resulting in a measurable alteration of the phototransduction cascade.

Official Administration Protocols

Sildenafil Genfar administration is governed by two distinct use protocols reflecting the specific condition being addressed. The medication is utilized for the oral route (tablet or suspension) and for intravenous (IV) injection in clinical settings.

Dosing and Frequency

For the as-needed use pattern, such as in erectile dysfunction (ED), the typical oral starting dose is 50 mg, which can be adjusted within the range of 25 mg to 100 mg. This single dose must be restricted to no more than once per day.

For the fixed maintenance pattern used in pulmonary arterial hypertension (PAH), the standard oral dose is 20 mg, administered three times a day (TID). Doses in this regimen must be separated by an interval of approximately four to six hours.

Administration Conditions and Adjustments

Tablets may be taken with or without food, although administration alongside a high-fat meal may lead to a slower rate of absorption.

A reduced starting dose of 25 mg is applied for certain populations, including older adults and patients presenting with severe renal or hepatic impairment when the drug is used for the ED indication. The IV injection is reserved for temporary use in patients who are unable to tolerate the oral preparation, where a 10 mg IV dose corresponds to the 20 mg oral dose.

Evidence for use in Erectile Dysfunction (ED)

The clinical research for Sildenafil primarily consists of Randomized Controlled Trials (RCTs) with defined study durations, which compared the compound to placebo. These studies were applied in research contexts involving fluctuating symptoms and monitored patient-reported outcomes related to the ability to achieve and maintain a penile erection. Research describing patterns observed in these studies contributed to the evidence base for functional changes in adult males.

Evidence for use in Pulmonary Arterial Hypertension (PAH)

For Pulmonary Arterial Hypertension, evidence includes placebo-controlled RCTs and long-term extension studies. The trials studied outcomes related to exercise capacity, measured by the 6-minute walk distance (6MWD), and evaluated shifts in the WHO Functional Class. Research describes patterns observed in these studies related to exercise capacity and changes in pulmonary hemodynamics over defined time intervals.

Research in Specific Populations and Long-Term Durability

Research explored Sildenafil in subgroups, including adult males with ED associated with diabetes mellitus, and pediatric patients with PAH. Long-term evidence is primarily derived from non-randomized extension studies that observed patient outcomes for periods extending up to two to three years. These studies provide documentation regarding the duration of observed changes but do not offer the same certainty as randomized, controlled long-term research.

Key Research Gaps and Remaining Uncertainty

A critical limitation in the PAH research is that the primary trials were not adequately powered to draw definitive conclusions about long-term survival. Long-term effects for continuous use are not fully established. Furthermore, a specific signal regarding a dose-related difference in mortality was observed in a long-term pediatric study, highlighting a key area where data requires strict regulatory oversight.

Common questions about Sildenafil Genfar (FAQ)

Q: What is Sildenafil Genfar used for?

Sildenafil Genfar is used to treat erectile dysfunction (ED), a condition where a man cannot achieve or maintain a hard erection suitable for sexual activity. It works by increasing blood flow to the penis when a man is sexually stimulated. This drug may also be used to treat pulmonary arterial hypertension (PAH) under the brand name Revatio, though Sildenafil Genfar is typically marketed for ED.

---

Q: How should I take Sildenafil Genfar?

Sildenafil Genfar should be taken exactly as prescribed by your healthcare provider. The standard way to take it for erectile dysfunction is by mouth, with or without food, approximately 30 minutes to 4 hours before sexual activity. It is usually recommended to take it about one hour before sexual activity for the best effect. You should not take this medicine more than once a day.

---

Q: What should I do if I miss a dose?

Sildenafil Genfar is typically taken on an as-needed basis for erectile dysfunction, so you are unlikely to miss a dose. If you are taking it regularly for pulmonary arterial hypertension (PAH), take the missed dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose. Do not take two doses at the same time.

---

Q: What are the common side effects of Sildenafil Genfar?

The most common side effects of Sildenafil Genfar include:

• Headache
• Flushing (a feeling of warmth)
• Upset stomach or indigestion
• Abnormal vision (such as blurred vision or a blue-tinge)
• Nasal congestion or runny nose
• Muscle pain or back pain

These side effects are generally mild and temporary. If any side effect persists or worsens, consult your healthcare provider.

---

Q: Can Sildenafil Genfar cause a painful or prolonged erection (Priapism)?

Yes, although rare, Sildenafil Genfar can cause priapism, which is an erection that is painful or lasts longer than 4 hours. Priapism is a medical emergency and can cause permanent damage to the penis if not treated immediately. If you have an erection that lasts longer than 4 hours, seek emergency medical help right away.

---

Q: Does Sildenafil Genfar interact with other medications?

Yes, Sildenafil Genfar interacts dangerously with certain medications, particularly those containing nitrates (like nitroglycerin, isosorbide dinitrate, or isosorbide mononitrate). Taking Sildenafil Genfar with nitrates can cause a sudden, severe drop in blood pressure that could be fatal. Do not take Sildenafil Genfar if you are also taking nitrate drugs or recreational drugs called 'poppers'.

It also interacts with other medications, including:

• Alpha-blockers (used for high blood pressure or prostate issues)
• HIV protease inhibitors
• Certain antifungals
• Other treatments for ED

Always inform your healthcare provider about all medicines and supplements you are taking before starting Sildenafil Genfar.

---

Q: Is Sildenafil Genfar safe for women or children?

Sildenafil Genfar for erectile dysfunction is generally not approved for use in women or children. Sildenafil (under the brand name Revatio) is sometimes used to treat pulmonary arterial hypertension (PAH) in children and women, but this is a different medical context. Women who are pregnant or breastfeeding should consult their doctor before taking any form of sildenafil. Keep this medication out of the reach of children.

---

Q: Can I drink alcohol or grapefruit juice while taking Sildenafil Genfar?

Limit or avoid consuming large amounts of alcohol while taking Sildenafil Genfar. Alcohol can increase the risk of side effects like headache, dizziness, and low blood pressure. It may also impair your ability to get an erection, counteracting the drug's effect.

Avoid drinking grapefruit juice or eating grapefruit while on this medication, as it can increase the amount of Sildenafil Genfar in your bloodstream, potentially increasing your risk of side effects.

---

Q: What is the difference between Sildenafil Genfar and Viagra?

Sildenafil is the active ingredient in both Sildenafil Genfar (the generic version) and Viagra (the original brand-name drug). They are medically equivalent, meaning they contain the same amount of the active ingredient and work the same way in the body. Sildenafil Genfar is typically less expensive than the brand-name Viagra.

How to Store and Dispose of Sildenafil Genfar

Sildenafil Genfar (Sildenafil Citrate) should be stored properly to maintain its stability and effectiveness. The medication should be kept at controlled room temperature, ideally between 20 C and 25 C (68 F and 77 F), with permitted excursions to 15 C–30 C.

It is essential to store the medication in its original container, tightly closed, and keep it away from areas with excess humidity. Do not freeze this product. Always ensure that the medication is stored out of the reach of children and pets.

For disposal, do not flush Sildenafil tablets down the toilet. To discard unwanted medication safely, mix the tablets with an undesirable substance, such as coffee grounds or cat litter, place the mixture in a sealed plastic bag, and then dispose of it in the household trash. Alternatively, utilize a community drug take-back program.